|Bid||153.46 x 100|
|Ask||153.56 x 100|
|Day's Range||152.23 - 154.90|
|52 Week Range||71.46 - 167.86|
|PE Ratio (TTM)||213.99|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
UTRECHT, Netherlands (AP) — Els van der Heijden, who has cystic fibrosis, was finding it ever harder to breathe as her lungs filled with thick, sticky mucus. Despite taking more than a dozen pills and inhalers a day, the 53-year-old had to stop working and scale back doing the thing she loved best, horseback riding.
Vertex Pharmaceuticals Inc NASDAQ/NGS:VRTX
Gilead Sciences (GILD) has gained 13% during the past three months as investors have started to bet that the beaten-down biotech stock has finally found a bottom. The iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.1% to $303.67.